CN103417796A - Composite drug combination capable of effectively treating hand-foot-mouth diseases - Google Patents

Composite drug combination capable of effectively treating hand-foot-mouth diseases Download PDF

Info

Publication number
CN103417796A
CN103417796A CN2013103679151A CN201310367915A CN103417796A CN 103417796 A CN103417796 A CN 103417796A CN 2013103679151 A CN2013103679151 A CN 2013103679151A CN 201310367915 A CN201310367915 A CN 201310367915A CN 103417796 A CN103417796 A CN 103417796A
Authority
CN
China
Prior art keywords
grams
foot
gram
mouth disease
hand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013103679151A
Other languages
Chinese (zh)
Inventor
戴忠明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHANGSHU HUAGANG PHARMACEUTICAL Co Ltd
Original Assignee
CHANGSHU HUAGANG PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGSHU HUAGANG PHARMACEUTICAL Co Ltd filed Critical CHANGSHU HUAGANG PHARMACEUTICAL Co Ltd
Priority to CN2013103679151A priority Critical patent/CN103417796A/en
Publication of CN103417796A publication Critical patent/CN103417796A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a composite drug combination capable of effectively treating hand-foot-mouth diseases. The composite drug combination is composed of seven kinds of natural plant medicinal materials including, by weight ratio, 4.6-5.4g of radix astragali, 5.3-6.2g of honeysuckle, 2.8-3.5g of oriental wormwood, 3.4-4.3g of feverfew, 5.9-6.8g of mint, 2.5-3.3g of acorus gramineus and 3.7-4.5g of manyleaf paris rhizome. The composite drug combination is carefully developed by adopting various pure-natural medicinal materials, is heathy and environmental-friendly, has efficacy of liver protecting, antiinflammatory effect and body building, improving of immunity of lung and respiratory system, improving immunity of the organism, clearing of heat and toxic material, relieving of swelling and pain and dampness resolving and promoting of Qi circulation, and has good prevention and treatment effect on the hand-foot-mouth diseases.

Description

A kind of composite combined medicine of effective treatment hand-foot-mouth disease
Technical field
The present invention relates to medicine field, particularly relate to a kind of composite combined medicine of effective treatment hand-foot-mouth disease.
Background technology
Hand-foot-mouth disease is a kind of child's infectious disease, has another name called dermexanthesis vesicle stomatitis.Multiplely be born in child below 5 years old, can cause the herpes at the positions such as hands, foot, oral cavity, the minority infant can cause the complication such as myocarditis, pulmonary edema, AME.If indivedual children with serious disease PD are fast, cause death.This disease take that to form ulcer after hands, foot and oral mucosa herpes or ulceration be main clinic symptoms.Especially some infant, infect this after being ill normal diet be subject to serious impact, greatly be unfavorable for child's growth, therefore, be badly in need of a kind of medicine that can prevent and treat and protected.
Summary of the invention
The technical problem that the present invention mainly solves is to provide a kind of composite combined medicine of effective treatment hand-foot-mouth disease, this composite combined medical instrument of effectively treating hand-foot-mouth disease have protect the liver, antiinflammatory is kept fit, improve lung and respiratory system immunocompetence, the characteristics of enhancing human body immunity power, heat-clearing and toxic substances removing, reducing swelling and alleviating pain, removing dampness circulation of qi promoting.
For solving the problems of the technologies described above, the technical scheme that the present invention adopts is: the composite combined medicine that a kind of effective treatment hand-foot-mouth disease is provided, the composite combined medicated bag of described effective treatment hand-foot-mouth disease is drawn together the Radix Astragali, Flos Lonicerae, Herba Artemisiae Scopariae, Flos Chrysanthemi, Herba Menthae, seven kinds of natural plant crude drugs of Rhizoma Acori Graminei and Rhizoma Paridis, in the composite combined medicine of described effective treatment hand-foot-mouth disease, each composition is respectively by weight ratio: the Radix Astragali 4.6 grams-5.4 gram, Flos Lonicerae 5.3 grams-6.2 gram, Herba Artemisiae Scopariae 2.8 grams-3.5 gram, Flos Chrysanthemi 3.4 grams-4.3 gram, Herba Menthae 5.9 grams-6.8 gram, Rhizoma Acori Graminei 2.5 grams-3.3 gram, Rhizoma Paridis 3.7 grams-4.5 gram.
In a preferred embodiment of the present invention, the shared weight proportion of each composition of composite combined medicine of described effective treatment hand-foot-mouth disease is specially the Radix Astragali 5.3 grams, Flos Lonicerae 6.1 grams, Herba Artemisiae Scopariae 3.4 grams, Flos Chrysanthemi 4.2 grams, Herba Menthae 6.7 grams, Rhizoma Acori Graminei 3.2 grams, Rhizoma Paridis 4.4 grams.
In a preferred embodiment of the present invention, the shared weight proportion of each composition of composite combined medicine of described effective treatment hand-foot-mouth disease is specially the Radix Astragali 4.7 grams, Flos Lonicerae 5.4 grams, Herba Artemisiae Scopariae 2.9 grams, Flos Chrysanthemi 3.5 grams, Herba Menthae 6.1 grams, Rhizoma Acori Graminei 2.6 grams, Rhizoma Paridis 3.8 grams.
The invention has the beneficial effects as follows: the present invention adopts multiple pure natural medical material meticulously to develop, health environment-friendly, and have protect the liver, antiinflammatory is kept fit, improve lung and respiratory system immunocompetence, the effect of enhancing human body immunity power, heat-clearing and toxic substances removing, reducing swelling and alleviating pain, removing dampness circulation of qi promoting, and hand-foot-mouth disease is had to good prevention and therapeutic effect.
The specific embodiment
Below will the technical scheme in the embodiment of the present invention be clearly and completely described, obviously, described embodiment is only a part of embodiment of the present invention, rather than whole embodiment.Embodiment based in the present invention, those of ordinary skills, not making all other embodiment that obtain under the creative work prerequisite, belong to the scope of protection of the invention.
A kind of composite combined medicine of effective treatment hand-foot-mouth disease, the composite combined medicated bag of described effective treatment hand-foot-mouth disease is drawn together the Radix Astragali, Flos Lonicerae, Herba Artemisiae Scopariae, Flos Chrysanthemi, Herba Menthae, Rhizoma Acori Graminei and seven kinds of natural plant crude drugs of Rhizoma Paridis, in the composite combined medicine of described effective treatment hand-foot-mouth disease, each composition is respectively by weight ratio: the Radix Astragali 4.6 grams-5.4 gram, Flos Lonicerae 5.3 grams-6.2 gram, Herba Artemisiae Scopariae 2.8 grams-3.5 gram, Flos Chrysanthemi 3.4 grams-4.3 gram, Herba Menthae 5.9 grams-6.8 gram, Rhizoma Acori Graminei 2.5 grams-3.3 gram, Rhizoma Paridis 3.7 grams-4.5 gram.
Further, the shared weight proportion of each composition of composite combined medicine of described effective treatment hand-foot-mouth disease is specially the Radix Astragali 5.3 grams, Flos Lonicerae 6.1 grams, Herba Artemisiae Scopariae 3.4 grams, Flos Chrysanthemi 4.2 grams, Herba Menthae 6.7 grams, Rhizoma Acori Graminei 3.2 grams, Rhizoma Paridis 4.4 grams.
Further, the shared weight proportion of each composition of composite combined medicine of described effective treatment hand-foot-mouth disease is specially the Radix Astragali 4.7 grams, Flos Lonicerae 5.4 grams, Herba Artemisiae Scopariae 2.9 grams, Flos Chrysanthemi 3.5 grams, Herba Menthae 6.1 grams, Rhizoma Acori Graminei 2.6 grams, Rhizoma Paridis 3.8 grams.
The Radix Astragali can improve lung and respiratory system immunocompetence, enhancing human body immunity power.
Flos Lonicerae has the effect of heat-clearing and toxic substances removing, wind-heat dissipating.
The effect that Herba Artemisiae Scopariae has clearing away heat-damp and promoting diuresis, protects the liver.
The effect that Flos Chrysanthemi has is antibacterial, antiinflammatory is kept fit, promote the production of body fluid.
Herba Menthae has that removing toxic substances is relieved inflammation or internal heat, the effect of wind-dispelling heat-dissipating.
Rhizoma Acori Graminei has the removing dampness circulation of qi promoting; The sharp numbness of dispeling the wind; The effect of reducing swelling and alleviating pain.
Rhizoma Paridis has the effect of heat-clearing and toxic substances removing, reducing swelling and alleviating pain, the arresting convulsion of cool liver.
Carry out proportioning by each composition Different Weight percentage ratio, make the properties of product that obtain just differ.
The beneficial effect that the present invention effectively treats the composite combined medicine of hand-foot-mouth disease is: the present invention adopts multiple pure natural medical material meticulously to develop, health environment-friendly, and have protect the liver, antiinflammatory is kept fit, improve lung and respiratory system immunocompetence, the effect of enhancing human body immunity power, heat-clearing and toxic substances removing, reducing swelling and alleviating pain, removing dampness circulation of qi promoting, and hand-foot-mouth disease is had to good prevention and therapeutic effect.
The foregoing is only embodiments of the invention; not thereby limit the scope of the claims of the present invention; every equivalent structure or conversion of equivalent flow process that utilizes description of the present invention to do; or directly or indirectly be used in other relevant technical field, all in like manner be included in scope of patent protection of the present invention.

Claims (3)

1. the effective composite combined medicine for the treatment of hand-foot-mouth disease, it is characterized in that: the composite combined medicated bag of described effective treatment hand-foot-mouth disease is drawn together the Radix Astragali, Flos Lonicerae, Herba Artemisiae Scopariae, Flos Chrysanthemi, Herba Menthae, Rhizoma Acori Graminei and seven kinds of natural plant crude drugs of Rhizoma Paridis, in the composite combined medicine of described effective treatment hand-foot-mouth disease, each composition is respectively by weight ratio: the Radix Astragali 4.6 grams-5.4 gram, Flos Lonicerae 5.3 grams-6.2 gram, Herba Artemisiae Scopariae 2.8 grams-3.5 gram, Flos Chrysanthemi 3.4 grams-4.3 gram, Herba Menthae 5.9 grams-6.8 gram, Rhizoma Acori Graminei 2.5 grams-3.3 gram, Rhizoma Paridis 3.7 grams-4.5 gram.
2. the composite combined medicine of effective treatment hand-foot-mouth disease according to claim 1, it is characterized in that, the shared weight proportion of each composition of composite combined medicine of described effective treatment hand-foot-mouth disease is specially the Radix Astragali 5.3 grams, Flos Lonicerae 6.1 grams, Herba Artemisiae Scopariae 3.4 grams, Flos Chrysanthemi 4.2 grams, Herba Menthae 6.7 grams, Rhizoma Acori Graminei 3.2 grams, Rhizoma Paridis 4.4 grams.
3. the composite combined medicine of effective treatment hand-foot-mouth disease according to claim 1, it is characterized in that, the shared weight proportion of each composition of composite combined medicine of described effective treatment hand-foot-mouth disease is specially the Radix Astragali 4.7 grams, Flos Lonicerae 5.4 grams, Herba Artemisiae Scopariae 2.9 grams, Flos Chrysanthemi 3.5 grams, Herba Menthae 6.1 grams, Rhizoma Acori Graminei 2.6 grams, Rhizoma Paridis 3.8 grams.
CN2013103679151A 2013-08-22 2013-08-22 Composite drug combination capable of effectively treating hand-foot-mouth diseases Pending CN103417796A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013103679151A CN103417796A (en) 2013-08-22 2013-08-22 Composite drug combination capable of effectively treating hand-foot-mouth diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013103679151A CN103417796A (en) 2013-08-22 2013-08-22 Composite drug combination capable of effectively treating hand-foot-mouth diseases

Publications (1)

Publication Number Publication Date
CN103417796A true CN103417796A (en) 2013-12-04

Family

ID=49643536

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013103679151A Pending CN103417796A (en) 2013-08-22 2013-08-22 Composite drug combination capable of effectively treating hand-foot-mouth diseases

Country Status (1)

Country Link
CN (1) CN103417796A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435984A (en) * 2014-11-27 2015-03-25 侯德润 Drug for treating infantile hand-foot-mouth disease and preparation method of drug
CN105012729A (en) * 2015-07-09 2015-11-04 杜仁波 Traditional Chinese medicine composition for treating hand-foot-and-mouth disease
CN105327201A (en) * 2015-09-29 2016-02-17 谢桂凤 Pharmaceutical for treating infantile hand-foot-mouth disease

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101926901A (en) * 2010-09-01 2010-12-29 吴业刚 Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof
CN102349991A (en) * 2011-05-29 2012-02-15 王红芳 Composition for killing virus and preventing influenza and cold prevention plaster prepared by composition
CN103054988A (en) * 2013-01-11 2013-04-24 东莞广州中医药大学中医药数理工程研究院 Application for granules capable of clearing heat and expelling damp in preparation for traditional Chinese medicine for preventing and treating hand-foot-and-mouth disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101926901A (en) * 2010-09-01 2010-12-29 吴业刚 Chinese medicinal oral liquid for treating chronic rhinitis and sinusitis and preparation method thereof
CN102349991A (en) * 2011-05-29 2012-02-15 王红芳 Composition for killing virus and preventing influenza and cold prevention plaster prepared by composition
CN103054988A (en) * 2013-01-11 2013-04-24 东莞广州中医药大学中医药数理工程研究院 Application for granules capable of clearing heat and expelling damp in preparation for traditional Chinese medicine for preventing and treating hand-foot-and-mouth disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
覃耀真,等: "中医分型辨治小儿手足口病50例", 《广西中医药》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435984A (en) * 2014-11-27 2015-03-25 侯德润 Drug for treating infantile hand-foot-mouth disease and preparation method of drug
CN105012729A (en) * 2015-07-09 2015-11-04 杜仁波 Traditional Chinese medicine composition for treating hand-foot-and-mouth disease
CN105327201A (en) * 2015-09-29 2016-02-17 谢桂凤 Pharmaceutical for treating infantile hand-foot-mouth disease

Similar Documents

Publication Publication Date Title
CN102973862B (en) Chinese medicine preparation for treating skin itch
CN102091191B (en) Medicament for treating chronic pharyngitis
CN102772694B (en) Traditional Chinese medicine composition for treating wind-heat type common cold
CN102091250B (en) Traditional Chinese medicine for treating acute tonsillitis
CN103417796A (en) Composite drug combination capable of effectively treating hand-foot-mouth diseases
CN103182019A (en) Traditional Chinese medicine composition for treating ROU (recurrent oral ulcer)
CN103800827A (en) Traditional Chinese medicine for treating liver cancer
CN101537141A (en) Pharmaceutical composition for clearing away heat and toxic material, dispelling wind and eliminating swelling and relieving sore throat to be sensible
CN102552512A (en) Traditional Chinese medicine used for treating hepatitis B
CN101810754A (en) Buccal tablets for curing chronic pharyngitis
CN102018874A (en) Traditional Chinese medicine preparation for treating swelling
CN113018344A (en) Traditional Chinese medicine for preventing and treating influenza and upper respiratory tract infection
CN101461888A (en) Traditional Chinese medicine formula for treating pharyngitis
CN102772648B (en) Traditional Chinese medicine composition for curing oral ulcer
CN102309731A (en) Traditional Chinese medicine decoction for treating tuberculous arthritis
CN102973906A (en) Weiyangling and preparation method thereof
CN102018838A (en) Medicine for treating chronic rhinitis
CN105055580A (en) Traditional Chinese medicine for treating cold
CN1217694C (en) A reducing fever anti-cold medicine combination and the preparation process thereof
CN105641666A (en) Traditional Chinese medicine formula treating chronic rhinitis
CN106880722A (en) It is a kind of to treat compound traditional Chinese medicine composite of rhinitis and preparation method thereof
CN105412407A (en) Traditional Chinese medicine composition for preventing and curing flu as well as preparation method and application thereof
CN104800598A (en) Traditional Chinese medicine for treating pharyngitis
CN103977313A (en) Diuresis promoting and itching relieving pills and preparation method thereof
CN105664079A (en) Medicine for treating pneumonia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20131204